Maya Zlatanova speaks with the CEO of Pharmaxi LLC, Yuriy Lebed. Pharmaxi is a clinical research organization based in Ukraine and operating in the Eastern European market. It was one of the first clinical organizations to restore clinical trials after the war began. Maya and Yuriy examine the clinical trial process during the war in Ukraine and the challenges in patient recruitment. They dive deeper into success factors in clinical trials, patient and data safety, etc.  Here are the key topics that they discussed: (2:34) How were clinical trials run prior to the war in Ukraine (4:09) Factors that make Ukraine an appealing clinical trial destination (8:45) How the clinical trial landscape changed after the war (11:16) What factors are relevant to Ukraine’s success today? (14:45) What are Ukraine’s current challenges in running successful clinical trials? (17:48) What extra measures are taken to ensure patient and data safety? (19:34) What was the approval procedure for the first clinical trial after the war started? Tune in to learn more! Maya Zlatanova, CEO of Trialhub Yuriy Lebed, CEO of Pharmaxi LLC See More TrialhubPharmaxi LLC